Case Study | September 09, 2011

Overcoming Geographical Challenges to Deliver State-of-the-Art Radiation Therapy

Remote Planning software facilitates treatment for patients in rural Montana

Sponsored by Accuray

Dr. Lyle Harrison is no stranger to the challenges of delivering healthcare to patients in rural markets. Since 1997, he has been living and providing radiation oncology services in the MonDak region of eastern Montana and western North Dakota.

One of his biggest frustrations was not being able to provide radiation services to every patient he saw because of limitations in the technology and expertise available. As a result, many of his patients were forced to travel hundreds of miles to bigger cities where they could get the treatment they needed.

After working in the region for years, Dr. Harrison began focusing on building a radiation oncology practice to serve the Sidney, Mont., area and evaluating the technology that would meet the needs of patients in the region. “We discussed the type of patients we wanted to treat at the Sidney Health Center and quickly came to the decision that we didn’t want to have any patient that we couldn’t treat,” said Dr. Harrison. “Because of that desire, the TomoTherapy radiation therapy platform made the most sense for us.”

The TomoTherapy system gave the center several advantages over conventional radiation therapy systems, said Dr. Harrison. They include: the flexibility to treat a wide range of indications; the knowledge that they could achieve gold-standard treatment quality for their patients; improved clinical confidence via integrated daily image guidance; highly conformal radiation delivery, which helps reduce side effects that commonly occur after conventional treatments, and the ability to deliver hypofractionated treatments to shorten treatment time for patients who have to travel great distances.

While TomoTherapy technology was just what Sidney Health Center needed to support its commitment to being a comprehensive community health facility, there was still another challenge: how to have the complete team in place to support the system. This team would need to include a dosimetrist and physicist, in addition to the radiation oncologists and radiation therapists.

Finding individuals with expertise in dosimetry and physics was a difficult proposition in Sidney, which is a small community of less than 5,000 residents, in a county in eastern Montana with a total population of about 10,000. Further complicating matters is that the region is in the midst of an oil boom, which has resulted in a shortage of housing that would prevent these medical specialists from moving close to the health center to work, should they desire to relocate.

“Being in a rural area and not having the right people onsite is very difficult to overcome,” said Jen Doty, the center’s clinical director. “It was really important for us to have remote planning capabilities. We had this great TomoTherapy technology, but didn’t have the staff to get the planning done for the patients we had lined up.”

The TomoTherapy system’s Remote Planning solution gave Sidney Health Center the ability to work with dosimetrists and physicists in cities more than 900 miles away to create the plans and begin treating patients. With Remote Planning, the dosimetrists, physicists and physicians working at Sidney Health Center are able to access full TomoTherapy treatment planning capabilities from virtually any remote location.

The planning experience is exactly as it would be on TomoTherapy Planning Stations installed within the cancer center’s TomoTherapy network. Furthermore, the performance of these local workstations is not impacted by remote planning instances. The remote users can run the Remote Planning software virtual machines from their location via an encrypted SSL connection, enterprise Citrix connection, VPN or other secure network access connection.

The Remote Planning capabilities have even given the employees located at the Sidney Health Center more flexibility in doing their job. “Our dosimetrists often work outside the standard office hours, so they can call me in the evening when they’re finished with a plan and I can review,” said Dr. Harrison. “It helps us speed up the process for the patients the next day because the plan can be revised and approved before we get in the office the next morning.”

TomoTherapy technology and its Remote Planning capabilities have been instrumental in enabling Sidney Health Center to deliver state-of-the art care to patients in its rural area, rather than forcing those individuals to travel hundreds of miles to larger cities. It is using its TomoTherapy system to treat a wide range of indications, including prostate, breast, lung and metastatic cancers, as well as whole brain, lymphomas and superficial lesions.

“We’ve been able to treat everything that is treated in a larger city’s community center, as well as more complex cases, with the TomoTherapy system,” said Rick Haraldson, CEO of Sidney Health.

“The TomoTherapy platform has met all of our expectations – from installation and training to treatment and the ability to leverage our relationships with experienced dosimetrists and physicists in other cities to develop our treatment plans,” said Dr. Harrison. “I’ve been able to offer treatments that I would have never been able to treat before with conventional radiation therapy machines and would have had to refer out to others.

“It’s very important in a rural environment that no case comes through the door that we wouldn’t be comfortable treating,” he added. “We always felt that we should be able to provide the best care possible – at the same or greater quality as bigger centers – and TomoTherapy technology has helped us meet those expectations in every way.”

Related Content

Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to augment medical research and enable scientific discoveries, presented findings in Hepatocellular Carcinoma (HCC) with Cleveland Clinic at the 2021 European Society of Medical Oncology (ESMO) conference.

Illustration courtesy of Cleveland Clinic

News | Artificial Intelligence | September 24, 2021
September 24, 2021 — Owkin, a startup that deploys...
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021
September 24, 2021 — The ...
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...